A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
168
mentions
- X 136
- News 14
- Facebook 10
- Instagram 3
- +3 more
Sabine Schranz
PubHawk tracks social media discussions for 1 article by authors named Sabine Schranz.
Mentions
168
Peak: 82 in May 2024
across 1 tracked article
Extended reach
3,457,519
potential audience
Total likes
367
Video views
3,834
Mentions per month
Oct 2014 – Jun 2025Where it's discussed
-
X / Twitter136 posts
-
News14 articles
-
Facebook10 posts
-
Instagram3 posts
-
YouTube2 videos
-
Blogs2 articles
-
Bluesky1 posts
Tracked by PubHawk
Most discussed articles
From PubMed
All publications
Searching PubMed…